Prostate Cancer Canada would like to recognize the Movember Foundation as a key funder of this program.

Prostate Cancer Canada is pleased to announce the awarding of 16 innovative Movember Pilot Grants. This year PCC received a total of 125 applications to its Movember Pilot Grant competition, representing an increase of more than 50% over the number of applications received in 2011. 

In order to decide which research projects should receive funding, each application is thoroughly reviewed by at least two cancer experts. These experts make recommendations to PCC regarding which research projects to fund. This process is called 'peer review'. The peer review process ensures that only the most meritorious research is supported. This year's successful research projects explore many different areas of prostate cancer including novel treatment therapies and the development of new tools to help better predict disease progression.


Movember Established Investigator Pilot Grants

Investigator	Host Institution	Project Title	Total Award	Award Period
Christina Addison	Ottawa Hospital Research Institute	Regulation of prostate cancer metastasis and response to therapy by beta1 integrins	$149,887	July 1, 2012 - December 31, 2014
Robert Bristow	Princess Margaret Hospital	High-throughput discovery of prostate tumour initiating cells markers for prognosis and personalized medicine	$150,000	July 1, 2012 - December 31, 2014
Michael Cox	Vancouver Prostate Centre	Regulation of DNA methyltransferases (DNMTs)  by Gli proteins and its effects on progression of prostate cancer	$150,000	July 1, 2012 - December 31, 2014
Robert Day	University of Sherbrooke	The development of PACE4 inhibitors for novel prostate cancer therapies	$150,000	July 1, 2012 - December 31, 2014
Louis Lacombe	Centre Hospitalier Universitaire de Québec - L'Hotel-Dieu de Québec	Immune score as a new possible approach to predict prostate cancer outcome after prostatectomy	$150,000	July 1, 2012 - December 31, 2014
Anne-Marie Mes-Masson	Centre Hospitalier de l'Université de Montréal	Involvement of IKKe in castration resistance and prostate cancer progression	$150,000	July 1, 2012 - December 31, 2014
Mark Trifiro	Jewish General Hospital	Novel targeted abiotic therapeutics and imaging agents for prostate cancer	$149,960	July 1, 2012 - December 31, 2014
Kishor Wasan	University of British Columbia	Role of SR-BI-mediated cholesterol influx and intercellular synthesis as potential sources of cholesterol required for de novo steroidogenesis in castration-resistant prostate cancer	$120,000	July 1, 2012 - June 30, 2014
Gang Zheng	University Health Network	Porphysome-enabled focal laser ablation of prostate cancer	$150,000	July 1, 2012 - December 31, 2014
Movember New Investigator Pilot Grants
Investigator	Host Institution	Project Title	Total Award	Award Period
Alison Allan	University of Western Ontario	Circulating tumour cells (CTCs) in prostate cancer: are we finding the real "bad guys"?	$149,758	July 1, 2012 - December 31, 2014
Hon Leong	London Health Sciences Centre	Non-invasive staging of prostate cancer: detection of circulating prostate microparticles using unique metastasis-specific antibody 1A5	$150,000	July 1, 2012 - December 31, 2014
Paulo Nuin	Queen's University	Meta-analysis of prognostic DNA copy number biomarkers for selection of unique combinations of FISH probes that correlate with aggressive CaP	$150,000	July 1, 2012 - December 31, 2014
Paul Park	Queen's University	EMT-associated genes as prognostic biomarkers in Gleason score 3+3 biopsies of prostatic adenocarcinoma	$150,000	July 1, 2012 - December 31, 2014
Frédéric Pouliot	Laval University	In vivo prostate cancer transcriptional signature detection using integrative multigenic molecular imaging	$150,000	July 1, 2012 - December 31, 2014
John Stagg	Centre de Recherche du  Centre Hospitalier de l'Université de Montréal	Targeting CD73 for treatment of prostate cancer	$150,000	July 1, 2012 - December 31, 2014
Amina Zoubeidi	Vancouver Prostate Centre	Persistent androgen receptor activation after maximum androgren blockade	$150,000	July 1, 2012 - December 31, 2014
More information about these programs.